TREVOR ROYCE, MS, MD, MPH, and Sheetal Kircher, MD, are the 2018–2019 ASCO Health Policy Fellows. Now entering its third year, the fellowship program offers oncologists the opportunity to gain the knowledge, skills, and experience necessary to shape regulatory and legislative policies that directly affect the practice environment and impact patients with cancer and their care teams.
Trevor Royce, MS, MD, MPH
DR. ROYCE is currently Chief Resident at the Harvard Radiation Oncology Program and Immediate Past Vice-Chair of the Association of Residents in Radiation Oncology Executive Committee. During his time at the University of North Carolina (UNC) at Chapel Hill School of Medicine, he spent a year as a Doris Duke Clinical Research Fellow conducting health services research with a focus on prostate cancer.
Before medical school, Dr. Royce pursued graduate school at Georgetown University in Washington, DC, and completed an internship in internal medicine at Brigham and Women’s Hospital in Boston. During residency, he obtained a Master of Public Health degree at the Harvard School of Public Health. Dr. Royce will join the faculty at UNC Chapel Hill this fall.
Sheetal Kircher, MD
DR. KIRCHER is a medical oncologist and Assistant Professor in the Department of Medicine at Northwestern University. She obtained her medical degree from Rush Medical College and completed her fellowship in medical oncology at Northwestern University. During her research fellowship at the Ann Arbor Veterans Affairs, she also obtained a Master’s degree in Health and Health Outcomes from the University of Michigan.
Dr. Kircher’s clinical focus is the treatment of gastrointestinal malignancies, and her research interests are related to health-care delivery throughout the cancer continuum. She currently serves as the Medical Director of the Survivorship Institute of Northwestern, where she oversees programmatic aspects of delivering survivorship care.
As ASCO Health Policy Fellows, Dr. Royce and Dr. Kircher will participate in the following activities:
© 2018. American Society of Clinical Oncology. All rights reserved.